CRISPR has captured the imagination of scientists worldwide, not to mention a Nobel Prize in 2020. Applications range from a plethora of basic research fields to diagnosing and curing genetic and infectious diseases and engineering longer-lived crops, and much more.
In 2018, Mary Ann Liebert, Inc., publishers announced the creation of The CRISPR Journal -- an international, multidisciplinary peer-reviewed journal publishing outstanding research on the myriad applications and underlying technology of CRISPR and related genome editing platforms. The Journal provides a high-profile venue for groundbreaking peer-reviewed research, as well as lively and provocative commentary, analysis, and debate.
Editor-in-Chief: Rodolphe Barrangou, PhD. Executive Editor: Kevin Davies PhD